ReviewClinical rheumatology2011
Evaluation of current therapeutic strategies in Behçet's disease.
Review in Clinical rheumatology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Efficacy and safety profile of anti-interleukin-1 treatment in Behçet's disease: a multicenter retrospective study.Clinical rheumatology · 2016Article
- Anakinra treatment in drug-resistant Behcet's disease: a case series.Clinical rheumatology · 2015Article
- Thrombosis in vasculitis: from pathogenesis to treatment.Thrombosis journal · 2015Article
- Evidence-based practice in Behçet's disease: identifying areas of unmet need for 2014.Orphanet journal of rare diseases · 2014Article
- Development of Immunopathogenesis Strategies to Treat Behçet's Disease.Pathology research international · 2012Article
- New Evidence-Based Treatment Approach in Behçet's Disease.Pathology research international · 2012Article
- New insights in the clinical understanding of Behçet's disease.Yonsei medical journal · 2012Article
- Hughes-Stovin syndrome.Orphanet journal of rare diseases · 2011Review
- Pulmonary artery aneurysm: Harbinger of an ominous disease.Annals of pediatric cardiologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Behçet's disease (BD) is a chronic relapsing vasculitis with multifunctional pathogenesis. The mucocutaneous and ocular lesions are the commonest manifestations, but BD also affects the musculoskeletal, intestinal, cardiac, and central nervous system. BD therapy is based on the suppression of the inflammatory process, using immunomodulating and immunosuppressive agents. In selected cases, invasive procedures may be required.
Indexed as
Identifiers
20842513What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.